Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0537 Transporter Info
Gene Name	RALBP1
Transporter Name	RalBP1-associated Eps domain-containing protein 2
Gene ID	10928
UniProt ID	Q8NFH8

Post-Translational Modification of This DT
Overview ofRALBP1 Modification Sites with Functional and Structural Information
Sequence	M E A A A A A A A A A A A A A A A G G G C G S G P P P L L L S E G E Q Q C Y S E L F A R C A G A A G G G P G S G P P E A A R V A P G T A T A A A G P V A D L F R A S Q L P A E T L H Q I T E L C G A K R V G Y F G P T Q F Y I A L K L I A A A Q S G L P V R I E S I K C E L P L P R F M M S K N D G E I R F G N P A E L H G T K V Q I P Y L T T E K N S F K R M D D E D K Q Q E T Q S P T M S P L A S P P S S P P H Y Q R V P L S H G Y S K L R S S A E Q M H P A P Y E A R Q P L V Q P E G S S S G G P G T K P L R H Q A S L I R S F S V E R E L Q D N S S Y P D E P W R I T E E Q R E Y Y V N Q F R S L Q P D P S S F I S G S V A K N F F T K S K L S I P E L S Y I W E L S D A D C D G A L T L P E F C A A F H L I V A R K N G Y P L P E G L P P T L Q P E Y L Q A A F P K P K W D C Q L F D S Y S E S L P A N Q Q P R D L N R M E K T S V K D M A D L P V P N Q D V T S D D K Q A L K S T I N E A L P K D V S E D P A T P K D S N S L K A R P R S R S Y S S T S I E E A M K R G E D P P T P P P R P Q K T H S R A S S L D L N K V F Q P S V P A T K S G L L P P P P A L P P R P C P S Q S E Q V S E A E L L P Q L S R A P S Q A A E S S P A K K D V L Y S Q P P S K P I R R K F R P E N Q A T E N Q E P S T A A S G P A S A A T M K P H P T V Q K Q S S K Q K K A I Q T A I R K N K E A N A V L A R L N S E L Q Q Q L K E V H Q E R I A L E N Q L E Q L R P V T V L
PTM type	X-Acetylation X-O-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	610
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at RALBP1 Lysine 610 has the potential to affect its expression or activity.
O-glycosylation
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	507
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at RALBP1 Threonine 507 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence REPS2			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	96
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at REPS2 Cystine 96 has the potential to affect its expression or activity.
Phosphorylation
Alanine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4], [5]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	194
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Alanine 194 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	253
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Alanine 253 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	445
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Alanine 445 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	491
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Alanine 491 has the potential to affect its expression or activity.
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	460
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Arginine 460 has the potential to affect its expression or activity.
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	449
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Asparticacid 449 has the potential to affect its expression or activity.
Glutamicacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	548
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Glutamicacid 548 has the potential to affect its expression or activity.
Glutamine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	186
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Glutamine 186 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	303
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Glycine 303 has the potential to affect its expression or activity.
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[6]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	557
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Leucine 557 has the potential to affect its expression or activity.
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	404
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Lysine 404 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	508
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Lysine 508 has the potential to affect its expression or activity.
Phenylalanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	259
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Phenylalanine 259 has the potential to affect its expression or activity.
Proline	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[4], [5]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	197
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Proline 197 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence RALBP1			[6]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	226
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Proline 226 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	478
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Proline 478 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	502
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Proline 502 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	543
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Proline 543 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	562
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Proline 562 has the potential to affect its expression or activity.
Serine	44 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Affecting the activity of RLIP76			[7]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Doxorubicin	Results for Drug	Incerasing the transport of doxorubicin
Modified Residue	Serine	Modified Location	118
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 118 have been reported to increase its transport activity.
PTM Phenomenon2	Affecting the activity of RLIP76			[7]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Doxorubicin	Results for Drug	Incerasing the transport of doxorubicin
Modified Residue	Serine	Modified Location	353
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 353 have been reported to increase its transport activity.
PTM Phenomenon3	Affecting the activity of RLIP76			[7]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Doxorubicin	Results for Drug	Incerasing the transport of doxorubicin
Modified Residue	Serine	Modified Location	509
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 509 have been reported to increase its transport activity.
PTM Phenomenon4	No significant effect			[7]
Role of PTM	No Significant Effect
Modified Residue	Serine	Modified Location	252
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 252 have been reported to have no significant effect on its expression or subcellular localisation, nor did it affect the rate of drug transport.
PTM Phenomenon5	Have the potential to influence RALBP1			[8], [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	121
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 121 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	172
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 172 has the potential to affect its expression or activity.
PTM Phenomenon7	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	187
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 187 has the potential to affect its expression or activity.
PTM Phenomenon8	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	191
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 191 has the potential to affect its expression or activity.
PTM Phenomenon9	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	195
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 195 has the potential to affect its expression or activity.
PTM Phenomenon10	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	198
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 198 has the potential to affect its expression or activity.
PTM Phenomenon11	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	199
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 199 has the potential to affect its expression or activity.
PTM Phenomenon12	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	213
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 213 has the potential to affect its expression or activity.
PTM Phenomenon13	Have the potential to influence RALBP1			[11], [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	217
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 217 has the potential to affect its expression or activity.
PTM Phenomenon14	Have the potential to influence RALBP1			[11], [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	218
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 218 has the potential to affect its expression or activity.
PTM Phenomenon15	Have the potential to influence RALBP1			[14], [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	239
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 239 has the potential to affect its expression or activity.
PTM Phenomenon16	Have the potential to influence RALBP1			[13], [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	240
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 240 has the potential to affect its expression or activity.
PTM Phenomenon17	Have the potential to influence RALBP1			[14], [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	241
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 241 has the potential to affect its expression or activity.
PTM Phenomenon18	Have the potential to influence RALBP1			[16], [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	254
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 254 has the potential to affect its expression or activity.
PTM Phenomenon19	Have the potential to influence RALBP1			[11], [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	258
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 258 has the potential to affect its expression or activity.
PTM Phenomenon20	Have the potential to influence RALBP1			[19], [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	260
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 260 has the potential to affect its expression or activity.
PTM Phenomenon21	Have the potential to influence RALBP1			[11], [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 269 has the potential to affect its expression or activity.
PTM Phenomenon22	Have the potential to influence RALBP1			[21], [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	270
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 270 has the potential to affect its expression or activity.
PTM Phenomenon23	Have the potential to influence RALBP1			[5], [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	304
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 304 has the potential to affect its expression or activity.
PTM Phenomenon24	Have the potential to influence RALBP1			[5], [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	385
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 385 has the potential to affect its expression or activity.
PTM Phenomenon25	Have the potential to influence RALBP1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	387
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 387 has the potential to affect its expression or activity.
PTM Phenomenon26	Have the potential to influence RALBP1			[11], [23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	406
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 406 has the potential to affect its expression or activity.
PTM Phenomenon27	Have the potential to influence RALBP1			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 422 has the potential to affect its expression or activity.
PTM Phenomenon28	Have the potential to influence RALBP1			[5], [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	441
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 441 has the potential to affect its expression or activity.
PTM Phenomenon29	Have the potential to influence RALBP1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	450
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 450 has the potential to affect its expression or activity.
PTM Phenomenon30	Have the potential to influence RALBP1			[22], [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	459
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 459 has the potential to affect its expression or activity.
PTM Phenomenon31	Have the potential to influence RALBP1			[11], [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	461
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 461 has the potential to affect its expression or activity.
PTM Phenomenon32	Have the potential to influence RALBP1			[11], [26]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	463
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 463 has the potential to affect its expression or activity.
PTM Phenomenon33	Have the potential to influence RALBP1			[10], [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	464
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 464 has the potential to affect its expression or activity.
PTM Phenomenon34	Have the potential to influence RALBP1			[10], [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	466
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 466 has the potential to affect its expression or activity.
PTM Phenomenon35	Have the potential to influence RALBP1			[19], [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	489
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 489 has the potential to affect its expression or activity.
PTM Phenomenon36	Have the potential to influence RALBP1			[27], [28]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	492
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 492 has the potential to affect its expression or activity.
PTM Phenomenon37	Have the potential to influence RALBP1			[20], [28]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	493
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 493 has the potential to affect its expression or activity.
PTM Phenomenon38	Have the potential to influence RALBP1			[4], [29]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 503 has the potential to affect its expression or activity.
PTM Phenomenon39	Have the potential to influence RALBP1			[19], [30]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	544
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 544 has the potential to affect its expression or activity.
PTM Phenomenon40	Have the potential to influence RALBP1			[19], [31]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	549
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 549 has the potential to affect its expression or activity.
PTM Phenomenon41	Have the potential to influence RALBP1			[19], [31]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	550
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 550 has the potential to affect its expression or activity.
PTM Phenomenon42	Have the potential to influence RALBP1			[13], [32]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	559
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 559 has the potential to affect its expression or activity.
PTM Phenomenon43	Have the potential to influence RALBP1			[10], [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	563
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 563 has the potential to affect its expression or activity.
PTM Phenomenon44	Have the potential to influence RALBP1			[32], [33]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	631
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Serine 631 has the potential to affect its expression or activity.
Threonine	11 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Affecting the activity of RLIP76			[7]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Doxorubicin	Results for Drug	Incerasing the transport of doxorubicin
Modified Residue	Threonine	Modified Location	297
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 297 have been reported to increase its transport activity.
PTM Phenomenon2	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	167
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 167 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	168
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 168 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence RALBP1			[5], [23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	185
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 185 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence RALBP1			[5], [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	189
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 189 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence RALBP1			[4], [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	405
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 405 has the potential to affect its expression or activity.
PTM Phenomenon7	Have the potential to influence RALBP1			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	421
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 421 has the potential to affect its expression or activity.
PTM Phenomenon8	Have the potential to influence RALBP1			[11], [34]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	446
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 446 has the potential to affect its expression or activity.
PTM Phenomenon9	Have the potential to influence RALBP1			[10], [22]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	465
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 465 has the potential to affect its expression or activity.
PTM Phenomenon10	Have the potential to influence RALBP1			[16], [33]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	479
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 479 has the potential to affect its expression or activity.
PTM Phenomenon11	Have the potential to influence RALBP1			[21], [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Threonine 487 has the potential to affect its expression or activity.
Tyrosine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence RALBP1			[35]
Role of PTM	Potential impacts
Modified Residue	Tyrosine
Experimental Material(s)	African green monkey kidney fibroblast-like (COS) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence RALBP1			[5], [36]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	165
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine 165 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence RALBP1			[5], [37]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine 203 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence RALBP1			[5], [38]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	212
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine 212 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence RALBP1			[5], [39]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine 227 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence RALBP1			[19], [40]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine 271 has the potential to affect its expression or activity.
PTM Phenomenon7	Have the potential to influence RALBP1			[11], [22]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	462
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine 462 has the potential to affect its expression or activity.
PTM Phenomenon8	Have the potential to influence RALBP1			[32], [41]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	558
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at RALBP1 Tyrosine 558 has the potential to affect its expression or activity.

References
1	Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis. J Bone Oncol. 2018 Sep 22;13:76-90.
2	Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease. J Pathol. 2017 Sep;243(1):78-88.
3	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
6	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
7	RLIP76: A Structural and Functional Triumvirate. Cancers (Basel). 2021 May 4;13(9):2206.
8	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
9	Studies of phosphoproteomic changes induced by nucleophosmin-anaplastic lymphoma kinase (ALK) highlight deregulation of tumor necrosis factor (TNF)/Fas/TNF-related apoptosis-induced ligand signaling pathway in ALK-positive anaplastic large cell lymphoma. Mol Cell Proteomics. 2010 Jul;9(7):1616-32.
10	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
11	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
12	Identification of Candidate Casein Kinase 2 Substrates in Mitosis by Quantitative Phosphoproteomics. Front Cell Dev Biol. 2017 Nov 22;5:97.
13	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
14	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
15	Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
16	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
17	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
18	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
19	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
20	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
21	Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
22	Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
23	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
24	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
25	Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
26	Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep. 2017 Mar 28;18(13):3242-3256.
27	CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
28	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
29	Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes. Sci Rep. 2016 Apr 15;6:24491.
30	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
31	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
32	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
33	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
34	Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
35	Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral. J Biol Chem. 1998 Jan 9;273(2):814-21.
36	Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes. Mol Cell Proteomics. 2016 Jun;15(6):2076-92.
37	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
38	Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Mol Cell Proteomics. 2016 Aug;15(8):2671-85.
39	Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer. Mol Cell Proteomics. 2015 Nov;14(11):2887-900.
40	Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages. Mol Cell Proteomics. 2016 Oct;15(10):3203-3219.
41	Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response. Mol Cell Proteomics. 2017 May;16(5):891-910.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence